A new aberrantly spliced BCR-ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemia

被引：0

作者：

Naumann, Nicole ^{[1
]}

Bross-Bach, Ulrike ^{[2
]}

Seifarth, Wolfgang ^{[1
]}

Fabarius, Alice ^{[1
]}

Hofmann, Wolf-Karsten ^{[1
]}

Saussele, Susanne ^{[1
]}

Spiess, Birgit ^{[1
]}

机构：

[1] Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Sci Lab, Pettenkofer Str 22, D-68169 Mannheim, Germany

[2] Univ Hosp Tubingen, Dept Internal Med, Clin Hematol Oncol Clin Immunol & Rheumatol, Tubingen, Germany

来源：

EJHAEM | 2022年 / 3卷 / 04期

关键词：

BCR-ABL1; CML; qRT-PCR; rare transcript; splice variant; BCR-ABL TRANSCRIPT; RESIDUAL DISEASE; INSERTION; CML; SEQUENCE; PCR;

D O I：

10.1002/jha2.553

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Quantitative reverse transcription polymerase chain reaction (qRT-PCR) of BCR-ABL1 transcript level is an essential part of routine disease monitoring in patients with chronic myeloid leukemia. One patient sample (e13a2 transcript detected by nested PCR) attracted attention by revealing an aberrantly spliced BCR-ABL1 transcript variant e13a1. The last 38 base pairs (bp) of BCR exon 13 were replaced by a 37 bp insertion of the ABL1 intron 1-2/exon 1 sequence. The rare aberrant BCR-ABL1 fusion transcript can cause discrepancies in molecular diagnostics. This scenario highlights the importance of an individual characterization of the BCR-ABL1 fusion sequence in case of unclear qRT-PCR results.

引用

页码：1339 / 1342

页数：4

共 16 条

[1] Amabile M, 1999, HAEMATOLOGICA, V84, P573
[2] A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia
Branford, S
Rudzki, Z
Hughes, TP
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (03) : 635 - 637
[3] Crampe Mireille, 2017, Hematol Oncol Stem Cell Ther, V10, P85, DOI 10.1016/j.hemonc.2016.02.002
[4] MINIMAL RESIDUAL DISEASE AFTER BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA DETECTED BY THE POLYMERASE CHAIN-REACTION
CROSS, NCP
LIN, F
BUNGEY, J
GOLDMAN, JM
[J]. LEUKEMIA & LYMPHOMA, 1993, 11 : 39 - 43
[5] CROSS NCP, 1994, LEUKEMIA, V8, P186
[6] Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR
Emig, M
Saussele, S
Wittor, H
Weisser, A
Reiter, A
Willer, A
Berger, U
Hehlmann, R
Cross, NCP
Hochhaus, A
[J]. LEUKEMIA, 1999, 13 (11) : 1825 - 1832
[7] A novel BCR-ABL, fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia
Hochhaus, A
Reiter, A
Skladny, H
Melo, JV
Sick, C
Berger, U
Guo, JQ
Arlinghaus, RB
Hehlmann, R
Goldman, JM
Cross, NCP
[J]. BLOOD, 1996, 88 (06) : 2236 - 2240
[8] A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia
McCarron, S. L.
Haslam, K.
Kelly, J.
Duggan, C.
Langabeer, S. E.
[J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (01) : e1 - e2
[9] BCR-ABL gene variants
Melo, JV
[J]. BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02): : 203 - 222
[10] A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study
Sadia, Hajra
Siddiqui, Rubina T.
Nasim, Anwar
[J]. CANCER GENETICS AND CYTOGENETICS, 2010, 201 (01) : 57 - 61

← 1 2 →